Borrower record · Q2 2026
Specialty Pharma III
As filed by 8 BDCs · period end 30 June 2026NAICS 31-33 · Manufacturing6 name variants under review
Eight lenders report $75.7m of Specialty Pharma III at Q2 2026, marked at par. First-Lien Senior Secured on all 14 positions whose seniority a filer disclosed.
- Filed fair value
- $75.7m
- 14 funded positions
- Reporting lenders
- 8
- across 14 filed positions
- Aggregate mark
- 100.0c
- cost filed on all 14 positions
- Median spread
- 475bp
- over SOFR, 14 tranches
- Maturities to
- 2032
- one date, 23 December 2032
- Periods on record
- 5
- first filed Q2 2025
How this total is counted
- Every figure above is the sum of 14 funded positions filed by 8 BDCs, each one cited below.
- Counted from the Q2 2026 filings imported for this build, the latest of them filed 20 August 2026. A schedule filed after that date is not in these figures and will appear when the property is rebuilt.
- 6 filed name variants are under review against this borrower. Until they are resolved, anything filed under those names is counted nowhere on this page.
Pricing as filed
14 floating tranches · SOFR475bp on all 14 floating tranches — every filer reports the same spread.
Capital structure
First-Lien Senior Secured, on all 14 positions whose seniority a filer disclosed.
Rate structure
Floating, on all 14 positions whose interest type a filer disclosed.
Maturity profile
all 14 funded positions dated6.5 years to maturity, weighted by fair value across the 14 dated positions.
Where the lenders disagree
8 filers disclosed a costLender marks on the same debt differ by up to 1.1c.
Credit flags
No lender reports this borrower on non-accrual, and no filed tranche pays in kind.
Not in the filings
- No period-by-period totals. Different lenders reported each of the 5 periods on record, so the movement between them would be a change in who filed, not in the borrower.
- Sector rests on 6 filers' labels; 2 of the 8 lenders filed none.
Sign up for free
Who holds it, and where they mark it.
8 lenders hold the same credit and mark it differently. Behind the gate, one row each — for this borrower and for every other one on this site, free and with no limit on how many you read.
- The spread between the highest and lowest lender mark
- Quarter-on-quarter movement across 5 periods
- Peer comparison against borrowers with the same lenders
- The 10-Q or 10-K behind every row, by accession number
Every filing behind this page
8 filers · Q2 2026| Filer | CIK | Form | Period | Filed | Accession |
|---|---|---|---|---|---|
| Carlyle Credit Solutions, Inc. | 0001702510 | 10-Q | 2026-06-30 | 2026-08-11 | 0001702510-26-000084 |
| Carlyle Secured Lending, Inc. (CGBD) | 0001544206 | 10-Q | 2026-06-30 | 2026-08-06 | 0001544206-26-000055 |
| LGAM Private Credit LLC | 0001983514 | 10-Q | 2026-06-30 | 2026-08-11 | 0001193125-26-344644 |
| Morgan Stanley Direct Lending Fund (MSDL) | 0001782524 | 10-Q | 2026-06-30 | 2026-08-06 | 0001193125-26-337915 |
| North Haven Private Income Fund A LLC | 0001973476 | 10-Q | 2026-06-30 | 2026-08-10 | 0001193125-26-342387 |
| North Haven Private Income Fund LLC | 0001851322 | 10-Q | 2026-06-30 | 2026-08-10 | 0001193125-26-342549 |
| Onex Direct Lending BDC Fund | 0001860424 | 10-Q | 2026-06-30 | 2026-08-07 | 0001193125-26-339194 |
| T Series BDC LLC | 0001885968 | 10-Q | 2026-06-30 | 2026-08-11 | 0001193125-26-344703 |
Related borrowers
Same lenders
Same sector